Tardive dyskinesia and informed consent

Sovner, Robert; Dimascio, Alberto; Berkowitz, David A.; Randolph, Peter S.

doi:10.1016/s0033-3182(78)71009-1

Cited by 29 publications

(5 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…243-44), not all patients at risk are informed. For instance, one article (Sovner et al 1978) incorrectly held that because patients were not at high risk until they had taken neuroleptics for more than a year, there was no reason to tell patients of the risks of TD until a year of continuous drug therapy had elapsed. Jeste and Wyatt (1981), despite finding high TD prevalence rates, argue that patients and family should be told that the risk of TD cannot be estimated for any individual patient.…”

Section: Malpractice Litigation and Informed Consentmentioning

confidence: 99%

Tardive Dyskinesia: Barriers to the Professional Recognition of an Iatrogenic Disease

Brown¹,

Funk²

1986

Journal of Health and Social Behavior

View full text Add to dashboard Cite

show abstract

Section: Malpractice Litigation and Informed Consentmentioning

confidence: 99%

Tardive Dyskinesia: Barriers to the Professional Recognition of an Iatrogenic Disease

Brown¹,

Funk²

1986

Journal of Health and Social Behavior

View full text Add to dashboard Cite

show abstract

“…Consent forms (Sovner et al 1978) have been suggested as a possible solution to the problem of informed consent regarding neuroleptic treatment, but they present their own dilemmas. The consensus appears to be that they should not be used as a substitute for discussions between patients and psychiatrists but rather as documentation that these discussions have taken place.…”

Section: Clinical Recommendationsmentioning

confidence: 99%

Treatment of Late-life Schizophrenia With Neuroleptics

Jeste¹,

Lacro

Gilbert

et al. 1993

Schizophrenia Bulletin

View full text Add to dashboard Cite

There is a death of literature on the effects of neuroleptics in older schizophrenia patients. In this article, we review the available literature and present findings from our own studies. Neuroleptics are effective in the treatment of late-life schizophrenia, although older patients generally need lower dosages than younger subjects. Neuroleptics, however, carry a relatively high risk of side effects such as tardive dyskinesia (TD) in middle-aged and elderly patients. By the end of 1 year of a prospective longitudinal study of neuroleptic treatment, we found a 26 percent cumulative incidence of TD among schizophrenia patients over age 45. If neuroleptics are withdrawn, there is a significant risk of a schizophrenic relapse; however, that risk is no greater in older patients than in younger ones. We offer clinical recommendations for the use of neuroleptics in the treatment of late-life schizophrenia.

show abstract

“…Die meisten Autoren halten allerdings eine Aufklärung vor Beginn der Neuroleptikatherapie nicht für erforderlich. So schlug Ayd(1977) vor, den Patienten erst 3 Mona-te nach Beginn der Therapie zu unterrichten, Sovner et al (1978) hielten es für vertretbar, ein Jahr nach Beginn der Therapie abzuwarten. Carey (1978) bemerkte hierzu, der Patient solle zunächst einmal die Vorteile der Neuroleptika kennenlernen, bevor er vor die Entscheidung gestellt wird, sie wegen eventuell auftretender Spätfolgen wieder abzusetzen.…”

Section: Die Selbstbestimmungsaufklärung Im Sinneunclassified

Aufklärung und Information in der Psychiatrie

Luderer¹

1989

Fortschr Neurol Psychiatr

View full text Add to dashboard Cite

All physicians are obliged to inform their patients about their disease and about course, purpose and risks of diagnostic and therapeutic procedures. Many physicians, however, try to avoid the dialogue with the patients particularly if disaggreable details are to be communicated. This is valid both for somatic medicine and for psychiatry. The openness of information in psychiatry depends on the patient's disease. Schizophrenic patients receive comprehensive information less frequently than patients suffering from mania, major depression, alcoholism and other dependencies. The label "schizophrenia" is generally paraphrased, the possibility of residual damage and the long-term side effects of neuroleptics are not mentioned by many physicians. Patients' knowledge about diagnosis and medical treatment does not depend on the duration of their illness and on the diagnosis but on individual factors: patients with secondary education and patients whose physicians regard comprehensive information to be favourable are better informed. Information about diagnosis and therapy can help the patients to understand their illness and to enhance compliance if the individual experience of the patients, their disease concept and their medical knowledge are taken into consideration. Information can be regarded as an important part of the relation between doctor and patient.

show abstract

Tardive dyskinesia and informed consent

Cited by 29 publications

References 18 publications

Tardive Dyskinesia: Barriers to the Professional Recognition of an Iatrogenic Disease

Tardive Dyskinesia: Barriers to the Professional Recognition of an Iatrogenic Disease

Treatment of Late-life Schizophrenia With Neuroleptics

Aufklärung und Information in der Psychiatrie

Contact Info

Product

Resources

About